Quinupristin-dalfopristin (RP 59500) is an injectable streptogramin an
tibiotic. It possesses a wide spectrum of activity against Gram-positi
ve bacteria including methicillin-resistant staphylococci, glycopeptid
e-resistant Enterococcus faecium and penicillin-resistant pneumococci.
Quinupristin-dalfopristin has activity against some anaerobes and sel
ected Gram-negative pathogens. Quinupristin-dalfopristin, by way syner
gism of between its 2 components, is unaffected by most forms of bacte
rial resistance. Rare forms of macrolide-lincosamide-streptogramin gro
up B resistance may affect its activity; however, at present the incid
ence of strains with this type of resistance remains low. Quinupristin
-dalfopristin is bactericidal against streptococci and staphylococci b
ut has weak or no bactericidal activity against enterococci. In a comp
assionate use programme, 67% of 95 evaluable patients with vancomycin-
resistant Gram-positive infections or intolerant of vancomycin showed
improvement with eradication of infection.